It appears as a lyophilized white powder for injection in a colorless transparent vial.
Botulax 100 IU contains 100 units (IU) of Clostridium botulinum toxin type A, 0.5 milligrams of albumin (human), and 0.9 milligrams of sodium chloride in a sterile, vacuum-dried form without a preservative. Botulinum toxin type A neurotoxin: purified from Clostridium botulinum type A Albumin: Human serum albumin, bulking and stabilizing agent and adhesion reducer. KP grade NaCl: Bulking agent and keeping isotonicity during formulation KP grade Developmental status: 2007.5: reported nonclinical study 2008.3: reported clinically study Phase l 2009.7: Finished Phase lll clinically study Characteristics of Botulax: Higher specific activity than those of other company’s botulinum toxin products by improving lyophilization process Facility: GMP approved by KFDA
Mode of action
Botulinum Toxin Type A blocks signals from the nerves to the muscles. The injected muscle can no longer contract, which causes the wrinkles to relax and soften. It is most often used on forehead lines, crow’s feet (lines around the eye), and frown lines.
Features and Benefits
Botulax guarantees high patient satisfaction. Potency variation is strictly controlled to within 91-115 units/ vial, more stringent than the legally required range. The size of the toxin complex is 900kDa, minimize the spread of botulinum toxin outside of the injection site. Such a large and homogeneous size of the toxin complex ensures a precise and uniform effect at the time of injection, guaranteeing high patient satisfaction with Botulax. Botulax is providing more choices. Botulax was launched in the market as a 100 unit product. Development of 25, 50, and 200-unit products are underway, “one vial for one patient” injection will be realized soon to minimize the risk of secondary infection.